Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $22.7 million.

  • Assembly Biosciences' Change in Acquisitions & Divestments fell 4209.18% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.8 million, marking a year-over-year increase of 228.47%. This contributed to the annual value of $130.7 million for FY2024, which is 10103.05% up from last year.
  • Per Assembly Biosciences' latest filing, its Change in Acquisitions & Divestments stood at $22.7 million for Q3 2025, which was down 4209.18% from $34.5 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Change in Acquisitions & Divestments high stood at $66.4 million for Q1 2021, and its period low was $10.0 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $26.4 million (2025), whereas its average is $28.6 million.
  • Per our database at Business Quant, Assembly Biosciences' Change in Acquisitions & Divestments plummeted by 6666.67% in 2023 and then surged by 14786.62% in 2024.
  • Over the past 5 years, Assembly Biosciences' Change in Acquisitions & Divestments (Quarter) stood at $43.0 million in 2021, then tumbled by 48.84% to $22.0 million in 2022, then decreased by 15.0% to $18.7 million in 2023, then surged by 82.89% to $34.2 million in 2024, then plummeted by 33.63% to $22.7 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $22.7 million for Q3 2025, versus $34.5 million for Q2 2025 and $26.4 million for Q1 2025.